✦ LIBER ✦

Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII

✍ Scribed by Serena Maria Passamonti; Paolo Bucciarelli; Rossella Bader; Ida Martinelli

Book ID: 116914343
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 163 KB
Volume: 126
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2010.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-fatal major bleeding during treatmen

Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX

✍ J. F. Van Der Heijden; B. Rekké; B. A. Hutten; F. J. M. Van Der Meer; M. G. H. R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

24 Correction of INR and Coagulation Fac

24 Correction of INR and Coagulation Factor Levels in a Randomized Clinical Trial of Four-Factor Prothrombin Complex Concentrate (PCC-4) Versus Plasma for Urgent Vitamin K Antagonist Reversal

✍ M.A. Refaai; J.N. Goldstein; T.J. Milling; H. Foehl; B. Hug; R. Sarode 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Effect of warfarin on plasma concentrati

Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance

✍ S. Kumar; J. R. M. Haigh; G. Tate; M. Boothby; D. N. Joanes; J. A. Davies; B. E. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

Polymorphic variation at the -202 locus

Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk

✍ Eva S. Schernhammer; Susan E. Hankinson; David J. Hunter; Marie J. Blouin; Micha 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 2 views

## Abstract Previous reports have suggested an association between circulating IGFBP‐3 levels and the risk of premenopausal breast cancer, and a single nucleotide polymorphism (SNP) in the promoter region of IGFBP‐3 (nucleotide ‐202) was shown to influence transcription. There is prior evidence tha